BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29359427)

  • 1. Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.
    Gong Q; Schaubel DE
    Pharm Stat; 2018 Mar; 17(2):117-125. PubMed ID: 29359427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doubly robust estimator for net survival rate in analyses of cancer registry data.
    Komukai S; Hattori S
    Biometrics; 2017 Mar; 73(1):124-133. PubMed ID: 27479200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating differences in restricted mean lifetime using observational data subject to dependent censoring.
    Zhang M; Schaubel DE
    Biometrics; 2011 Sep; 67(3):740-9. PubMed ID: 21039400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event.
    Schaubel DE; Zhang M
    Lifetime Data Anal; 2010 Oct; 16(4):451-77. PubMed ID: 20063183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of non-ignorable missing and left-censored longitudinal data using a weighted random effects tobit model.
    Sattar A; Weissfeld LA; Molenberghs G
    Stat Med; 2011 Nov; 30(27):3167-80. PubMed ID: 21898524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semiparametric estimator of the bivariate distribution function for censored gap times.
    de Uña-Álvarez J; Amorim AP
    Biom J; 2011 Feb; 53(1):113-27. PubMed ID: 21259312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiparametric methods to contrast gap time survival functions: Application to repeat kidney transplantation.
    Shu X; Schaubel DE
    Biometrics; 2016 Jun; 72(2):525-34. PubMed ID: 26501480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling restricted mean survival time under general censoring mechanisms.
    Wang X; Schaubel DE
    Lifetime Data Anal; 2018 Jan; 24(1):176-199. PubMed ID: 28224260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating lifetime or episode-of-illness costs under censoring.
    Basu A; Manning WG
    Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable selection using inverse probability of censoring weighting.
    Kojima M
    Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobit model for outcome variable is limited by censoring in nursing research.
    Lin KC; Cheng SF
    Nurs Res; 2011; 60(5):354-60. PubMed ID: 21873917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regression-based method for estimating mean treatment cost in the presence of right-censoring.
    Carides GW; Heyse JF; Iglewicz B
    Biostatistics; 2000 Sep; 1(3):299-313. PubMed ID: 12933511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slope estimation in the presence of informative right censoring: modeling the number of observations as a geometric random variable.
    Mori M; Woolson RF; Woodworth GG
    Biometrics; 1994 Mar; 50(1):39-50. PubMed ID: 8086614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric temporal process regression of survival-out-of-hospital.
    Zhan T; Schaubel DE
    Lifetime Data Anal; 2019 Apr; 25(2):322-340. PubMed ID: 29796979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.